BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 111 filers reported holding BIODELIVERY SCIENCES INTL IN in Q2 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $354,000 | -14.1% | 114,200 | 0.0% | 0.02% | -28.1% |
| Q3 2021 | $412,000 | -20.5% | 114,200 | -21.1% | 0.03% | -22.0% |
| Q2 2021 | $518,000 | -19.6% | 144,700 | -12.1% | 0.04% | -28.1% |
| Q1 2021 | $644,000 | -8.8% | 164,700 | -2.1% | 0.06% | -16.2% |
| Q4 2020 | $706,000 | +6.2% | 168,200 | -5.6% | 0.07% | -5.6% |
| Q3 2020 | $665,000 | -17.2% | 178,200 | -3.3% | 0.07% | -23.4% |
| Q2 2020 | $803,000 | +13.3% | 184,200 | -1.6% | 0.09% | +3.3% |
| Q1 2020 | $709,000 | -41.6% | 187,200 | -2.6% | 0.09% | -27.2% |
| Q4 2019 | $1,215,000 | +85.2% | 192,250 | +23.4% | 0.12% | +76.1% |
| Q3 2019 | $656,000 | +4.3% | 155,850 | +15.1% | 0.07% | +6.0% |
| Q2 2019 | $629,000 | +2.6% | 135,350 | +17.0% | 0.07% | -56.8% |
| Q1 2019 | $613,000 | +54.0% | 115,650 | +7.4% | 0.16% | +86.7% |
| Q4 2018 | $398,000 | +106.2% | 107,650 | +55.9% | 0.08% | -7.8% |
| Q3 2018 | $193,000 | +4.3% | 69,050 | +9.9% | 0.09% | +26.8% |
| Q2 2018 | $185,000 | +40.2% | 62,850 | +6.8% | 0.07% | +153.6% |
| Q1 2018 | $132,000 | -24.1% | 58,850 | 0.0% | 0.03% | -62.2% |
| Q4 2017 | $174,000 | +1.8% | 58,850 | 0.0% | 0.07% | +54.2% |
| Q3 2017 | $171,000 | -99.9% | 58,850 | +25.2% | 0.05% | +50.0% |
| Q2 2017 | $132,000,000 | +69.2% | 47,000 | +9.3% | 0.03% | +45.5% |
| Q1 2017 | $78,000,000 | -10.3% | 43,000 | -13.7% | 0.02% | +46.7% |
| Q4 2016 | $87,000,000 | +64344.4% | 49,850 | 0.0% | 0.02% | -37.5% |
| Q3 2016 | $135,000 | +64.6% | 49,850 | +42.4% | 0.02% | -7.7% |
| Q2 2016 | $82,000 | +811.1% | 35,000 | +1066.7% | 0.03% | +766.7% |
| Q1 2016 | $9,000 | -72.7% | 3,000 | -57.1% | 0.00% | -75.0% |
| Q4 2015 | $33,000 | 0.0% | 7,000 | +16.7% | 0.01% | 0.0% |
| Q3 2015 | $33,000 | -29.8% | 6,000 | 0.0% | 0.01% | -25.0% |
| Q2 2015 | $47,000 | -25.4% | 6,000 | 0.0% | 0.02% | -20.0% |
| Q1 2015 | $63,000 | -12.5% | 6,000 | 0.0% | 0.02% | -16.7% |
| Q4 2014 | $72,000 | -47.4% | 6,000 | -25.0% | 0.02% | -11.1% |
| Q3 2014 | $137,000 | -32.2% | 8,000 | -46.7% | 0.03% | -74.3% |
| Q2 2014 | $202,000 | – | 15,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 2,000,000 | $7,820,000 | 6.23% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $37,262,000 | 0.78% |
| EMC Capital Management | 193,906 | $758,000 | 0.54% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,486,454 | $13,632,000 | 0.50% |
| ALGERT GLOBAL LLC | 344,210 | $1,346,000 | 0.43% |
| Hillsdale Investment Management Inc. | 877,000 | $3,430,000 | 0.29% |
| Stanley-Laman Group, Ltd. | 349,465 | $1,366,000 | 0.22% |
| SHEPHERD KAPLAN KROCHUK, LLC | 94,000 | $368,000 | 0.14% |
| GLOBEFLEX CAPITAL L P | 178,474 | $698,000 | 0.13% |
| Zebra Capital Management LLC | 23,622 | $92,000 | 0.10% |